Celon Pharma Dividends and Buybacks

Dividend criteria checks 0/6

Celon Pharma is a dividend paying company with a current yield of 0.3%.

Key information

0.3%

Dividend yield

-2.8%

Buyback Yield

Total Shareholder Yield-2.5%
Future Dividend Yield1.2%
Dividend Growth2.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharezł0.080
Payout ratio23%

Recent dividend and buyback updates

Recent updates

A Piece Of The Puzzle Missing From Celon Pharma S.A.'s (WSE:CLN) Share Price

Aug 21
A Piece Of The Puzzle Missing From Celon Pharma S.A.'s (WSE:CLN) Share Price

Earnings Update: Celon Pharma S.A. (WSE:CLN) Just Reported And Analysts Are Boosting Their Estimates

Sep 24
Earnings Update: Celon Pharma S.A. (WSE:CLN) Just Reported And Analysts Are Boosting Their Estimates

Celon Pharma (WSE:CLN) Is In A Good Position To Deliver On Growth Plans

Jul 13
Celon Pharma (WSE:CLN) Is In A Good Position To Deliver On Growth Plans

We're Interested To See How Celon Pharma (WSE:CLN) Uses Its Cash Hoard To Grow

Nov 04
We're Interested To See How Celon Pharma (WSE:CLN) Uses Its Cash Hoard To Grow

We Think Celon Pharma (WSE:CLN) Can Afford To Drive Business Growth

Aug 04
We Think Celon Pharma (WSE:CLN) Can Afford To Drive Business Growth

Celon Pharma (WSE:CLN) Seems To Use Debt Quite Sensibly

May 23
Celon Pharma (WSE:CLN) Seems To Use Debt Quite Sensibly

Calculating The Intrinsic Value Of Celon Pharma S.A. (WSE:CLN)

Mar 02
Calculating The Intrinsic Value Of Celon Pharma S.A. (WSE:CLN)

Celon Pharma S.A. (WSE:CLN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Feb 09
Celon Pharma S.A. (WSE:CLN) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Celon Pharma's (WSE:CLN) Earnings Are Growing But Is There More To The Story?

Jan 20
Celon Pharma's (WSE:CLN) Earnings Are Growing But Is There More To The Story?

Celon Pharma (WSE:CLN) Shareholders Have Enjoyed A 12% Share Price Gain

Dec 24
Celon Pharma (WSE:CLN) Shareholders Have Enjoyed A 12% Share Price Gain

Celon Pharma (WSE:CLN) Has A Pretty Healthy Balance Sheet

Dec 03
Celon Pharma (WSE:CLN) Has A Pretty Healthy Balance Sheet

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: CLN is not paying a notable dividend for the Polish market, therefore no need to check if payments are stable.

Growing Dividend: CLN is not paying a notable dividend for the Polish market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

Celon Pharma Dividend Yield vs Market
How does CLN dividend yield compare to the market?
SegmentDividend Yield
Company (CLN)0.3%
Market Bottom 25% (PL)3.0%
Market Top 25% (PL)8.1%
Industry Average (Pharmaceuticals)2.5%
Analyst forecast (CLN) (up to 3 years)1.2%

Notable Dividend: CLN's dividend (0.3%) isn’t notable compared to the bottom 25% of dividend payers in the Polish market (2.99%).

High Dividend: CLN's dividend (0.3%) is low compared to the top 25% of dividend payers in the Polish market (8.07%).


Earnings Payout to Shareholders

Earnings Coverage: CLN is not paying a notable dividend for the Polish market.


Cash Payout to Shareholders

Cash Flow Coverage: CLN is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies